NCT00499317

Brief Summary

Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a condition with several causes of which some remain unknown. It is believed that some types of CP may be genetic or passed down (inherited) from one generation to the next. In this study, we are collecting genetic material and medical information to try to determine if genetic factors play a role in CP/CPPS. We will be collecting DNA (from Blood/Saliva sample) and urine from each participant. Bladder tissue from affected individuals will also be collected. Individuals and families with CP/CPPS will be enrolled. Family members of an individual with CP/CPPS are eligible whether or not they also experience CP/CPPS symptoms.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jan 2007Dec 2026

Study Start

First participant enrolled

January 15, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 9, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 11, 2007

Completed
18.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

August 14, 2023

Status Verified

August 1, 2023

Enrollment Period

19 years

First QC Date

July 9, 2007

Last Update Submit

August 9, 2023

Conditions

Keywords

UrgencyFrequencyPelvic painSexual dysfunctionErectile dysfunctionPainful intercourse

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We are collecting individuals with a diagnoses of CP/CPPS and their family members (with or without symptoms) from North America (United States and Canada). Preference is given to families with multiple affected individuals (males or females with IC/BPS/CPPS).

You may qualify if:

  • Have symptoms for at least 3 months within the preceding 6 months:
  • Pain in the pelvic area
  • Urinary frequency and/or
  • Urinary urgency and/or
  • Sexual dysfunction (erectile dysfunction)
  • Have CP/CPPS, Interstitial Cystitis (IC), Bladder Pain Syndrome BPS, or Bladder Fasciculation Syndrome (BFS)
  • Be willing to provide a blood/saliva, bladder tissue (from previous biopsy) and urine sample
  • Agree to complete several brief questionnaires
  • Family member of someone with CP/CPPS, BPS, IC or BFS
  • Live in the USA or Canada

You may not qualify if:

  • Major structural/anatomical urinary tract abnormalities
  • Underlying inborn or congenital conditions which affect the urinary tract
  • Surgery/chemotherapy in the pelvic area
  • Bacterial cause to CP/CPPS or recurrent Urinary tract infections (UTI)
  • Traumatic cause to CP/CPPS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital (BCH)

Boston, Massachusetts, 02115, United States

RECRUITING

Related Publications (3)

  • Propert KJ, Alexander RB, Nickel JC, Kusek JW, Litwin MS, Landis JR, Nyberg LM, Schaeffer AJ; Chronic Prostatitis Collaborative Research Network. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002 Jun;59(6):870-6. doi: 10.1016/s0090-4295(02)01601-1.

    PMID: 12031372BACKGROUND
  • Keay SK, Zhang CO. Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells. BJU Int. 2016 Jul;118(1):161-72. doi: 10.1111/bju.13457. Epub 2016 Mar 29.

    PMID: 26919663BACKGROUND
  • Dimitrakov JD. A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology. 2001 Aug;58(2):281. doi: 10.1016/s0090-4295(01)01138-4.

Biospecimen

Retention: SAMPLES WITH DNA

DNA sample via blood/saliva, bladder tissue and urine samples will be collected and stored.

MeSH Terms

Conditions

Cystitis, InterstitialPelvic PainSexual Dysfunction, PhysiologicalErectile DysfunctionDyspareunia

Condition Hierarchy (Ancestors)

CystitisUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital DiseasesGenital Diseases, MaleSexual Dysfunctions, PsychologicalMental DisordersGenital Diseases, Female

Study Officials

  • Catherine Brownstein, PhD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Professor of Genetics and Pediatrics, Harvard Medical School

Study Record Dates

First Submitted

July 9, 2007

First Posted

July 11, 2007

Study Start

January 15, 2007

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

August 14, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

Data from individual participants may be shared with other researchers. Other research studies will be approved by our internal review board and participants samples and data will be de-identified.

Shared Documents
SAP, ICF
Time Frame
We will store study information and samples indefinitely and may share this information with future collaborators. All shared samples and data will be de-identified.
Access Criteria
De-identified data may be shared with other CP/CPPS researchers or other BCH researchers

Locations